PT-141 (Bremelanotide) 10mg Nasal Spray Kit

PT-141 (Bremelanotide) is a synthetic peptide derived from Melanotan II, studied for its effects on the central nervous system. Unlike therapies that target vascular pathways, it acts on neural signaling related to sexual desire and arousal. Researchers have examined PT-141 in both men and women for its potential role in sexual function and behavioral response in controlled settings.

• Sexual Health Support: Enhances libido and sexual arousal.

• Unique Mechanism: Targets melanocortin receptors in the brain, not the vascular system.

• Broad Applications: Studied in both male erectile dysfunction and female sexual interest/arousal disorder.

• Rapid Onset: Effects reported within hours of administration.

• FDA-approved under the name Vyleesi for treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.

• Studies show improvement in erectile function in men.

• Demonstrated efficacy in individuals unresponsive to PDE5 inhibitors (e.g., sildenafil).

• Common side effects: flushing, nausea, headache, injection site reactions.

• Some individuals may experience transient increases in blood pressure.

• Contraindicated in uncontrolled hypertension or cardiovascular disease.

• Typical Protocol (FDA-approved use): 1.75 mg subcutaneous injection ~45 minutes before anticipated sexual activity.

• Frequency: Not to exceed one dose per 24 hours or 8 doses per month.

• Research protocols may vary depending on study design.